Clin2
NCT07844473Possibly a fitRecruiting

Magtrace dye to guide surgery for early breast cancer

Breast Cancer With Low to Intermediate HER2 ExpressionBreast Cancer (Triple Negative Breast Cancer (TNBC))Breast Cancer (Triple Negative Type)Breast Cancer - Infiltrating Ductal CarcinomaBreast Cancer - Ductal Carcinoma in Situ (DCIS)

Part of Cancer, Skin clinical trials.

This trial tests using a special dye called Magtrace to help surgeons find and remove the cancer and check nearby lymph nodes during breast-conserving surgery. It might help make the surgery more precise and avoid extra procedures.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
35 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are having breast-conserving surgery (lumpectomy), not removal of the whole breast.
  • You need a sentinel lymph node biopsy to check if cancer has spread to your lymph nodes.
  • You are able to have radiation therapy after surgery.
  • You do not have metastatic breast cancer that requires palliative surgery.
  • You have no allergy to Magtrace.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06610539Recruiting
Magnetic tracer for sentinel node biopsy in breast cancer

This study tests a magnetic tracer call Magtrace to help find and remove the first lymph node (sentinel node) during breast cancer surgery. The goal is to see if it works well for people having breast-conserving surgery.

Chapel Hill, North Carolina
NCT06169072Recruiting· Phase 2
Finding lymph nodes with a tiny dose of magnetic tracer in breast cancer

This trial is testing whether a very small amount of a magnetic tracer called Magtrace can help find lymph nodes that need to be checked for cancer spread during breast cancer surgery.

Gothenburg
NCT06104371Recruiting
Magnetic markers to find lymph nodes before chemo for breast cancer

This trial tests a new method using magnetic markers (Magtrace and Magseed) to find lymph nodes before chemotherapy. It may help doctors better target the lymph nodes that need to be removed during breast cancer surgery.

Gothenburg
NCT05427071Recruiting
Tracking a breast cancer marker to guide lymph node surgery

This study tests a special “marker” technique to help surgeons find affected lymph nodes in the armpit after chemotherapy. It may support more targeted surgery and help avoid unnecessary removal of healthy lymph nodes.

Hong Kong
NCT03796559Recruiting
Magnetic marker helps find breast cancer lymph nodes

This study uses a tiny magnetic marker (called Magseed) placed in a breast cancer–affected underarm lymph node, then tracks whether surgeons can find and remove the correct nodes after chemotherapy. It may help reduce the chance of missing cancer in the underarm while aiming for more accurate surgery.

Houston, Texas
NCT05142787Recruiting
Magnetic breast marker to guide removal of a lump

This study tests a magnetic marker system (placed in the breast or armpit area) to help surgeons find and remove a suspicious lump or lymph node. If you’re having breast/axillary lesion or node removal, this may help guide the procedure.

Bottrop

Hear when a new Breast Cancer With Low to Intermediate HER2 Expression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.